Research Article| Volume 17, ISSUE 4, P729-734, July 1995

Effects of long-term cilazapril treatment on glucose and lipid metabolism in hypertensive patients with non—insulin-dependent diabetes mellitus

      This paper is only available as a PDF. To read, Please Download here.


      The effects of long-term cilazapril treatment on glucose and lipid metabolism were assessed in 25 hypertensive patients with non—insulin-dependent diabetes mellitus (NIDDM). Patients were treated with 0.5 to 1 mg of cilazapril once daily or a combination of cilazapril and other anti-hypertensive drugs once daily for 48 weeks. Both systolic and diastolic blood pressures were significantly reduced (P < 0.001) throughout the study with no significant changes in heart rate and no adverse effects such as cough. There were no significant changes in body mass index or serum levels of glycated hemoglobin A1c, fructosamine, total cholesterol, triglycerides, lipoproteins (high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, and very-low-density lipoprotein cholesterol), or apolipoproteins (apo A-I, apo C-II, apo C-III, apo B, and apo E). Cilazapril caused a significant increase (P < 0.05) in levels of apo A-II and a significant decrease (P < 0.05) in the apo B:apo A-I ratio, an index of arteriosclerosis. These results suggest that cilazapril has favorable effects on glucose and lipid metabolism and that it may be useful as the first or second choice of antihypertensive drugs in hypertensive patients with NIDDM.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Clinical Therapeutics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Collins R
        • Peto R
        • MacMahon S
        • et al.
        Blood pressure, stroke and coronary heart disease. Part 2. Short-term reductions in blood pressure: Overview of randomized drug trials in their epidemiological context.
        Lancet. 1990; 335: 827-838
        • Weinberger MH
        Antihypertensive therapy and lipids. Evidence, mechanism and implications.
        Arch Intern Med. 1985; 145: 1102-1105
        • Pollare T
        • Lithell H
        • Berne CA
        Comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension.
        NEJM. 1989; 321: 869-873
        • The Working Group on Hypertension in Diabetes
        Statement on hypertension in diabetes mellitus.
        Arch Intern Med. 1987; 147: 1165-1166
        • Kigoshi T
        • Kaneko M
        • Nakano S
        • et al.
        Effect of long-term treatment with enalapril on blood pressure, serum lipids, lipoproteins and apoproteins in hypertensive subjects with non-insulin-dependent diabetes mellitus.
        J Drug Dev. 1992; 5: 89-94
        • Uchida K
        • Azukizawa S
        • Kigoshi T
        • et al.
        Effects of perindopril on glucose and lipid metabolism in patients with mild-to-moderate essential hypertension and glucose intolerance.
        Clin Ther. 1994; 16: 466-470
        • Shionoiri H
        • Sugimoto K
        • Minamisawa K
        • et al.
        Glucose and lipid metabolism during long-term treatment with cilazapril in hypertensive patients with or without impaired glucose metabolism.
        J Cardiovasc Pharmacol. 1990; 15: 933-938
        • Shieh AM
        • Sheu WH
        • Shen DC
        • et al.
        Improvement in metabolic risk factors for coronary heart disease associated with cilazapril treatment.
        Am J Hypertens. 1992; 5: 506-510
        • Paolisso G
        • Gambardella A
        • Verza M
        • et al.
        ACE inhibition improves insulin-sensitivity in aged insulin-resistant hypertensive patients.
        J Hypertens. 1992; 6: 175-179
        • Romo M
        Effect of cilazapril on lipids.
        Am J Med. 1993; 94 (Suppl 4A): 53-55
        • Gans ROB
        • Stehouwer CDA
        • Bilo HJ
        • et al.
        Effect of cilazapril on glucose tolerance and lipid profile in hypertensive patients with non-insulin-dependent diabetes mellitus.
        Neth J Med. 1993; 43: 163-173
        • Sasaki J
        • Arakawa K
        Effects of enalapril on serum lipoproteins in mild essential hypertension.
        Clin Ther. 1989; 11: 129-134